戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  pattern in females was associated with more seborrheic dermatitis.
2  as pityriasis versicolor, folliculitis, and seborrheic dermatitis.
3 s and may be caused by eczema, psoriasis, or seborrheic dermatitis.
4 pants were included, of whom 636 (14.5%) had seborrheic dermatitis.
5       Other factors were not associated with seborrheic dermatitis.
6 tal antioxidant capacity are associated with seborrheic dermatitis.
7  burden for dermatitis (atopic, contact, and seborrheic dermatitis), 0.29% for acne vulgaris, 0.19% f
8 ty, dietary pattern-derived PCA factors, and seborrheic dermatitis adjusted for confounders.
9 ," "atopic dermatitis," "acne," "vitiligo," "seborrheic dermatitis," "alopecia areata," and "lichen p
10 he epidemiologic associations of HTLV-I with seborrheic dermatitis and severe anemia in childhood.
11 ndicated for topical treatment of psoriasis, seborrheic dermatitis, and atopic dermatitis, whereas it
12 as cheilosis, angular stomatitis, glossitis, seborrheic dermatitis, and severe anemia with erythroid
13 atopic dermatitis, lichen planus, psoriasis, seborrheic dermatitis, and vitiligo.
14        Current topical treatment options for seborrheic dermatitis are limited by efficacy and/or saf
15                                 Dandruff and seborrheic dermatitis (D/SD) are common hyperproliferati
16 with significantly higher incidence rates of seborrheic dermatitis, eczema, and persistent hyperrefle
17 years) patients with a clinical diagnosis of seborrheic dermatitis for a 3-month or longer duration a
18 ailed estimation of the global prevalence of seborrheic dermatitis, highlighting significant variabil
19                                              Seborrheic dermatitis is a prevalent chronic inflammator
20 s) and placebo or azoles in the treatment of seborrheic dermatitis of the face and scalp in adults?
21 f Malassezia globosa in healthy subjects and seborrheic dermatitis or atopic dermatitis patients.
22 sitive associations with skin disorders (eg, seborrheic dermatitis, OR, 1.30; 95% CI, 1.15-1.46; psor
23 63 individuals and revealing a pooled global seborrheic dermatitis prevalence of 4.38% (95% CI, 3.58%
24                   Original investigations on seborrheic dermatitis prevalence were included after dup
25 ry outcome was the pooled estimate of global seborrheic dermatitis prevalence.
26                       Current treatments for seborrheic dermatitis provide only temporary relief.
27                                              Seborrheic dermatitis (SD) is a common skin disease char
28 ent of erythema, scaling, and itch caused by seborrheic dermatitis, supporting further investigation
29 are associated with several diseases such as seborrheic dermatitis, tinea versicolor, folliculitis, a
30   Skin manifestations ranged from atopic and seborrheic dermatitis to psoriasiform rash.
31  highly effective anti-fungal medication for seborrheic dermatitis, to generate a novel compound, ket
32 a high fruit intake was associated with less seborrheic dermatitis, whereas high adherence to a "West
33 involved in disorders including dandruff and seborrheic dermatitis, which together affect >50% of hum